Liptis Pharmaceuticals was a platinum sponsor of The Egyptian Arthroscopy Association (EGAA), 10th international congress
During The Egyptian Arthroscopy Association (EGAA) 10th international congress, Liptis Pharmaceuticals had a symposium on Wednesday 24th August, where
Dr. Lotfy Omar, the chairman of Liptis’ board of directors, gave a very insightful talk titled:
Dorofen as a Market Leader
Dr.Lotfy Omar dived deep into the topic highlighting how Dorofen made its way to the top in treating osteoarthritis and why it’s internationally recognized as the market leader. He also pointed out that Dorofen is registered in the US FDA and is listed as a brand name in Martindale pharmacopoeia, the 36th and 38th editions.
Prof. Adel Hamed and Ahmed Abdelaziz acted as chairmen of Liptis’ symposium.
Liptis Pharmaceuticals was a sponsor of The 4th Cardio Kheir Annual Meeting 2022 of El-Kheir Cath lab
It was an honor to sponsor The 4th Cardio Kheir Annual Meeting 2022 of El-Kheir Cath lab.
LIPTIS’ symposium hosted Prof. Antoine Lafont, Paris, France as the speaker giving a talk titled:
Rivaroxaban Superiority in NVAF, What’s new?
Prof. Adel El Etriby, Professor of Cardiology, Faculty of Medicine, Ain Shams University, as the chairman.
The 4th Cardio Kheir Annual Meeting 2022 of El-Kheir Cath lab was held on 08 September in collaboration with the Cardiology department at Mansoura University
It was a full-day scientific program covering the most updated important topics in the rapidly developing Interventional Cardiology field. This prestigious meeting included several hands-on workshops and was attended by highly selected eminent professors from all over the whole country who shared their experiences.
